ClinConnect ClinConnect Logo
Search / Trial NCT01099046

Stress Management Therapy for Meniere's Disease

Launched by OSAKA UNIVERSITY · Apr 3, 2010

Trial Information

Current as of June 12, 2025

Unknown status

Keywords

Meniere's Disease Stress Management Vasopressin V2 Receptor Water Intake Tympanic Tubing Regular Sleep Under Dark

ClinConnect Summary

BACKGROUND:

For the pathogenesis of inner ear hydrops resulting in Meniere's attacks, plasma vasopressin elevation due to stress and V2 receptor overexpression in the inner ear could be essential as a basis of this disease. In the present study, we'd like to find the effective and feasible way to reduce plasma vasopressin level in patients with Meniere's disease.

METHODS:

We estimate to enroll 200 Meniere's patients to four study groups in a randomized controlled trial at Osaka University Hospital during this study period 2010-2015. Patients are diagnosed as Meniere's patients according ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed as Meniere's patients according to the 1995 AAO-HNS criteria are included into this study.
  • Exclusion Criteria:
  • Patients refused our prepared four kinds of treatments are excluded from this study.

About Osaka University

Osaka University is a prestigious research institution located in Japan, renowned for its commitment to advancing medical science and healthcare. As a clinical trial sponsor, Osaka University leverages its extensive academic resources and cutting-edge research capabilities to facilitate innovative studies that aim to improve patient outcomes and enhance therapeutic interventions. The university collaborates with leading experts in various fields, ensuring rigorous scientific methodologies and adherence to ethical standards in clinical research. Its dedication to translating research findings into clinical practice positions Osaka University as a pivotal player in the global healthcare landscape.

Locations

Suita City, Osaka, Japan

Patients applied

0 patients applied

Trial Officials

Tadashi Kitahara, M.D.,Ph.D.

Principal Investigator

Department of Otolaryngology, Osaka University, School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials